Skip to main content

Table 1 Characteristics of included studies

From: Association of vascular endothelial growth factor polymorphisms with polycystic ovarian syndrome risk: a meta-analysis

Author

Year

Region

Ethnicity

PCOS Diagnostic criteria

Inclusion criteria for the control group

Control source

Genotyping method

SNP

NOS

Almawi [20]

2016

Bahrain

Caucasian

Rotterdam

age-and ethnically-matched; testosterone levels were within range (0.4–3.5 nmol/L) in the menstrual cycle follicular phase; no metabolic or endocrine diseases; BMI were between 18 and 45 kg/m2;without recent illness; without treatment may affect carbohydrate metabolism or hormonal levels within 3 months; without using anti-hypertensive, oral contraceptive, anti-inflammatory and lipid-lowering drugs

PB

RT-PCR

rs2010963

rs833061

rs3025039

rs699947

rs1570360

8

Bao [21]

2019

India

Asian

Rotterdam

age-and ethnically-matched; testosterone levels were within range (0.4–3.5 nmol/L) in the menstrual cycle follicular phase; no metabolic or endocrine diseases; BMI were between 18 and 45 kg/m2;without recent illness; without using anti-hypertensive, oral contraceptive, anti-inflammatory and lipid-lowering drugs

PB

RT-PCR

rs2010963

rs833061

rs3025039

rs699947

rs1570360

6

Ben Salem [22]

2016

Tunisia

Caucasian

Rotterdam

women with regular menstrual cycles and no evidence of hirsutism, acne, alopecia, or endocrinopathies; without treatment may affect carbohydrate metabolism or hormonal levels within 3 months

PB

RT-PCR

rs833061

rs3025039

rs699947

rs1570360

7

Ding [28]

2009

China

Asian

Rotterdam

women with regular menstrual cycles; with normal ovarian morphology; without treatment may affect carbohydrate metabolism or hormonal levels within 3 months; no metabolic or endocrine diseases;

HB

PCR

rs3025039

6

Gomes [23]

2019

Brazil

Caucasian

Rotterdam

age- matched; fertile women with no history of hyperandrogenism, menstrual dysfunction, infertility, or sonographic signal of PCOS; without using contraceptives, antiandrogens, statins, glucocorticoids or infertility medications within 6 months

PB

PCR-RFLP

(rs699947)

RT-PCR

(rs1570360)

rs699947

rs1570360

6

Guruvaiah [24]

2014

India

Asian

Rotterdam

fertile women with regular menstrual cycles and had a successful pregnancy record; with normal ovarian morphology confirmed by ultrasound

PB

PCR

rs2010963

rs833061

7

Huang [25]

2019

China

Asian

Rotterdam

women with normal menstrual cycles and had at least one successful pregnancy history; without endocrine disorders, family history of diabetes or sonographic signs of PCOS

HB

PCR-LDR

rs2010963

rs833061

7

Lee [26]

2008

Korea

Asian

Rotterdam

BMI-matched; with regular menstrual cycles; with normal ovarian morphology confirmed by ultrasound

PB

PCR

rs2010963

rs3025039

6

Li [29]

2014

China

Asian

Rotterdam

fertile women with regular menstrual cycles

HB

PCR-RFLP

rs1570360

6

Vural [27]

2009

Turkey

Caucasian

Rotterdam

fertile women without hyperandrogenism, history of menstrual dysfunction, infertility or sonographic signs of PCOS.

PB

PCR

rs2010963

rs833061

rs699947

6

  1. PCR polymerase chain reaction, RFLP restriction fragment length polymorphism, RT-PCR real time polymerase chain reaction, PCR-LDR polymerase chain reaction-ligase detection reaction, NOS Newcastle–Ottawa scale, PB Population-based, HB Hospital-based, BMI body mass index, PCOS polycystic ovary syndrome